Average Co-Inventor Count = 7.84
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Intellectual Property Development Limited (12 from 230 patents)
2. Cancer Research Technology Limited (1 from 262 patents)
12 patents:
1. 12285436 - Substituted pyridines as DNMT1 inhibitors
2. 12247033 - Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors
3. 11771711 - Substituted pyridines as DNMT1 inhibitors
4. 11485710 - Heterocyclic amides as kinase inhibitors
5. 11377440 - Modulators of stimulator of interferon genes (STING)
6. 10975056 - Substituted pyridines as inhibitors of DNMT1
7. 10940154 - Heterocyclic amides as kinase inhibitors
8. 10933070 - Heterocyclic amides as kinase inhibitors
9. 10899716 - Heterocyclic amides as kinase inhibitors
10. 10590085 - Heterocyclic amides as kinase inhibitors
11. 10292987 - Heterocyclic amides as kinase inhibitors
12. 9556152 - Heterocyclic amides as kinase inhibitors